Start main page content

 

Webinars

WBS Leadership DialoguesWits Business School presents its first lecture, titled: Covid-19 Vaccines – Challenges and Opportunities, in its Leadership Dialogues series.
Daily Maverick Vaccine Webinar SeriesUnderstanding the latest developments in SA’s Covid-19 vaccine rollout with Professors Shabir Madhi and Glenda Gray in conversation with Mark Heywood from Maverick Citizen.
Variations to vaccinesThe Sabinet and Wits University Press scientific update on the COVID-19 vaccine programme in South Africa.
Blueprint for the future of testing labs in AfricaWATCH as Professor Wendy Stevens details the extraordinary efforts of her team to upscale Covid testing.
The Inside Track: A Special Covid-19 Update​​​​​​​In an exclusive Inside Track webinar, Maverick Citizen Editor Mark Heywood and world-respected vaccinologist Professor Shabir Madhi will look at the unexpected suspension of the Ox1Cov-19 Vaccine VIDA-Trial, the possible explanations behind South Africa’s reported low death rate, whether it’s time the borders are opened and what we have understood so far about Covid-19, the virus that’s done all the damage.
Inequality and IndebtednessThe South African Research Chair in Equality, Law and Social Justice, the Southern Centre for Inequality Studies (SCIS), and the Mandela Institute, a Centre within the School of Law, of the University of the Witwatersrand hosted the third webinar in the series addressing critical issues of “Law, policy and inequality” titled ‘Inequality and Indebtedness’.
The Inside Track - A Special Covid-19 webinar discussionMaverick Citizen editor, Mark Heywood in conversation with Professor Shabir Madhi, professor of Vaccinology at Wits University as they take a critical look at the progress and the plan two months into the three month ‘State of Disaster’.
The Inside Track - The Race For The VaccineProfessor Shabir Madhi, the vaccinologist leading the charge in South Africa's new Covid-19 vaccine trial and Wits Professor Helen Rees GCOB, OBE, SA chairperson of SAHPRA and a regional and global expert on vaccine development and programmes.